# Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC – FDA Inspection, Jun 4, 2009

Source: https://www.keypedia.com/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/e2d3b98f-2847-45c3-9f43-d4401dcff5a7
Source feed: FDA_Inspections

> FDA inspection 590027 of Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC, June 04, 2009. Classification: No Action Indicated (NAI). 16 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 590027
- Company Name: Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
- Inspection Date: 2009-06-04
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1331288 - 2026-08-06](https://www.keypedia.com/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/3a30f17e-b96b-4038-afdf-5086e1071b60)
- [FDA Inspection 1311392 - 2026-04-08](https://www.keypedia.com/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/c5b9683d-dfc5-496a-afe9-353614bb2207)
- [FDA Inspection 1304580 - 2026-02-11](https://www.keypedia.com/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/97de66a3-38df-4231-8616-827b2267fbc3)
- FDA Inspection 1223617 - 2023-10-13
- [FDA Inspection 1218069 - 2023-09-19](https://www.keypedia.com/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/f4363d29-0083-495d-94cb-2f6416bd0726)

Company: https://www.keypedia.com/companies/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/0de9118f-18ec-45b8-b757-44f97c13c29c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c